SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-199916
Filing Date
2023-08-01
Accepted
2023-08-01 07:19:34
Documents
18
Period of Report
2023-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d532249d8k.htm   iXBRL 8-K 77606
2 EX-2.1 d532249dex21.htm EX-2.1 681973
3 EX-10.1 d532249dex101.htm EX-10.1 58301
4 EX-99.1 d532249dex991.htm EX-99.1 56783
5 EX-99.2 d532249dex992.htm EX-99.2 31922
6 EX-99.3 d532249dex993.htm EX-99.3 36990
  Complete submission text file 0001193125-23-199916.txt   1324829

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA eqrx-20230731.xsd EX-101.SCH 4401
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eqrx-20230731_def.xml EX-101.DEF 13380
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eqrx-20230731_lab.xml EX-101.LAB 22368
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eqrx-20230731_pre.xml EX-101.PRE 14283
12 EXTRACTED XBRL INSTANCE DOCUMENT d532249d8k_htm.xml XML 5533
Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 (617) 315-2255
EQRx, Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40312 | Film No.: 231129644
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences